Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DREAM study of temazepam for ICU sleep disruption
ACTRN12621000742875Phase 4Completed
- Sponsor
- Melbourne Health
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in sleep disorder comparing Temazepam with Placebo (2 arms). Primary endpoint: Total sleep duration. Started Oct 2020; status: completed.
02
Drugs
temazepam
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ACTRN12621000742875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000742875.